© 2018 Elsevier B.V. Background: ABC transporters have attracted considerable attention for their function as drug transporters in a broad range of tumours and are therefore considered as major players in cancer chemoresistance. However, less attention has been focused on their potential role as active players in cancer development and progression. Scope of review: This review presents the evidence suggesting that ABC transporters might have a more active role in cancer other than the well known involvement in multidrug resistance and discusses the potential strategies to target each ABC transporter for a specific tumour setting. Major conclusions: Emerging evidence suggests that ABC transporters are able to transport bioactive molecules ca...
Abstract One of the major problems related with anticancer chemotherapy is resistance against antica...
Multidrug resistance (MDR) is a serious problem that hampers the success of cancer pharmacotherapy. ...
The expression of membrane transporter is often altered in cancer cells compared to their correspond...
The efficacy of chemotherapy is one of the main challenges in cancer treatment and one of the major ...
The efficacy of chemotherapy is one of the main challenges in cancer treatment and one of the major ...
The phenomenon of multidrug resistance in cancer is often associated with the overexpression of the ...
The ATP-binding cassette (ABC) transporter superfamily consists of several proteins with a wide repe...
Introduction: Multidrug resistance (MDR) is the main cause of failure in cancer therapy. One mechani...
The role of ABC transporters in clinical practice ATP-binding cassette (ABC) transporters are a fami...
The role of ABC transporters in clinical practice ATP-binding cassette (ABC) transporters are a fami...
CSCs are responsible for the high rate of recurrence and chemoresistance of different types of cance...
CSCs are responsible for the high rate of recurrence and chemoresistance of different types of cance...
CSCs are responsible for the high rate of recurrence and chemoresistance of different type of cancer...
AbstractThe association of transporter proteins and cancer drug resistance has been known for approx...
Item does not contain fulltextFor most cancers, the treatment of choice is still chemotherapy despit...
Abstract One of the major problems related with anticancer chemotherapy is resistance against antica...
Multidrug resistance (MDR) is a serious problem that hampers the success of cancer pharmacotherapy. ...
The expression of membrane transporter is often altered in cancer cells compared to their correspond...
The efficacy of chemotherapy is one of the main challenges in cancer treatment and one of the major ...
The efficacy of chemotherapy is one of the main challenges in cancer treatment and one of the major ...
The phenomenon of multidrug resistance in cancer is often associated with the overexpression of the ...
The ATP-binding cassette (ABC) transporter superfamily consists of several proteins with a wide repe...
Introduction: Multidrug resistance (MDR) is the main cause of failure in cancer therapy. One mechani...
The role of ABC transporters in clinical practice ATP-binding cassette (ABC) transporters are a fami...
The role of ABC transporters in clinical practice ATP-binding cassette (ABC) transporters are a fami...
CSCs are responsible for the high rate of recurrence and chemoresistance of different types of cance...
CSCs are responsible for the high rate of recurrence and chemoresistance of different types of cance...
CSCs are responsible for the high rate of recurrence and chemoresistance of different type of cancer...
AbstractThe association of transporter proteins and cancer drug resistance has been known for approx...
Item does not contain fulltextFor most cancers, the treatment of choice is still chemotherapy despit...
Abstract One of the major problems related with anticancer chemotherapy is resistance against antica...
Multidrug resistance (MDR) is a serious problem that hampers the success of cancer pharmacotherapy. ...
The expression of membrane transporter is often altered in cancer cells compared to their correspond...